M&G Plc lifted its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 35.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 53,186 shares of the company's stock after buying an additional 13,922 shares during the quarter. M&G Plc's holdings in Nutrien were worth $2,717,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of NTR. Manning & Napier Advisors LLC purchased a new position in shares of Nutrien during the 2nd quarter worth $2,639,000. International Assets Investment Management LLC acquired a new position in Nutrien during the fourth quarter worth approximately $3,433,000. Vanguard Group Inc. increased its position in Nutrien by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 18,210,375 shares of the company's stock worth $1,025,790,000 after purchasing an additional 158,161 shares during the last quarter. SG Americas Securities LLC boosted its holdings in shares of Nutrien by 370.1% in the 1st quarter. SG Americas Securities LLC now owns 58,041 shares of the company's stock valued at $3,152,000 after purchasing an additional 45,695 shares during the last quarter. Finally, BNP Paribas purchased a new stake in shares of Nutrien during the 1st quarter valued at $1,146,000. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Stock Performance
Shares of NYSE:NTR traded up $0.34 during trading hours on Tuesday, hitting $46.51. The stock had a trading volume of 2,806,921 shares, compared to its average volume of 1,945,695. The stock's fifty day simple moving average is $50.73 and its 200 day simple moving average is $52.68. The firm has a market capitalization of $23.01 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 1.56 and a beta of 0.83. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.53 and a current ratio of 1.15. Nutrien Ltd. has a 1-year low of $44.90 and a 1-year high of $65.69.
Nutrien (NYSE:NTR - Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $2.34 EPS for the quarter, beating the consensus estimate of $2.19 by $0.15. The firm had revenue of $10.16 billion for the quarter, compared to analysts' expectations of $10.82 billion. Nutrien had a net margin of 3.01% and a return on equity of 7.31%. Nutrien's quarterly revenue was down 12.9% on a year-over-year basis. During the same quarter last year, the company earned $2.53 EPS. Sell-side analysts anticipate that Nutrien Ltd. will post 3.78 earnings per share for the current fiscal year.
Nutrien Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Stockholders of record on Friday, September 27th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 4.64%. The ex-dividend date of this dividend is Friday, September 27th. Nutrien's dividend payout ratio is presently 126.32%.
Analyst Ratings Changes
NTR has been the subject of a number of research reports. UBS Group decreased their target price on Nutrien from $67.00 to $66.00 and set a "buy" rating for the company in a report on Tuesday, July 9th. Scotiabank dropped their price objective on shares of Nutrien from $66.00 to $59.00 and set a "sector outperform" rating for the company in a research report on Monday. Hsbc Global Res cut Nutrien from a "hold" rating to a "moderate sell" rating in a research note on Friday, August 2nd. TD Securities lowered their target price on Nutrien from $69.00 to $67.00 and set a "buy" rating for the company in a research note on Thursday, August 1st. Finally, Piper Sandler dropped their target price on Nutrien from $56.00 to $55.00 and set an "underweight" rating on the stock in a report on Tuesday, June 11th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, Nutrien has an average rating of "Moderate Buy" and a consensus price target of $64.50.
View Our Latest Analysis on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).
![Institutional Ownership by Quarter for Nutrien (NYSE:NTR)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=NTR)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.